logo

For the Inventor, By the Inventor

Washingtonville, NY, United States of America

Steven R Schow

This inventor holds 7 USPTO granted patents and 3 published patent applications. Top assignee: American Cyanamid Company. Active years: 1994-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven R Schow. Retrieved from https://idiyas.com/inventor/steven-r-schow-g4b0e2nt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:

goldMedal7 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1994-1997

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5658945 - Urethanes and ureas that induce cytokine production (1997-08-19),
2. 5633280 - Urethanes and ureas that induce cytokine production (1997-05-27),
3. 5616612 - Urethanes and ureas that enhance the growth of bone marrow progenitor (1997-04-01),
4. 5602275 - Urethanes and ureas that induce cytokine production (1997-02-11),
5. 5545662 - Urethanes and ureas that induce cytokine production (1996-08-13),
6. 5430150 - Retroviral protease inhibitors (1995-07-04),
7. 5312831 - Urethanes and ureas that induce cytokine production (1994-05-17),

Title: The Innovative Contributions of Steven R. Schow

Introduction

Steven R. Schow is a notable inventor based in Washingtonville, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance immune response. With a total of 7 patents to his name, Schow's work has the potential to impact various medical treatments.

Latest Patents

One of Schow's latest patents focuses on urethanes and ureas that induce cytokine production. This invention relates to novel ureas and urethanes that stimulate cytokine production, which may be used to accelerate recovery from neutropenia associated with radio- or chemotherapy, bone marrow transplantation, or infections. The compounds developed in this invention, or pharmaceutical compositions employing these compounds, may be useful in treating cancer, AIDS, aplastic anemia, myelodysplastic syndrome, and infectious diseases. Additionally, they may enhance immune response.

Career Highlights

Steven R. Schow is associated with American Cyanamid Company, where he has been able to apply his innovative ideas in a collaborative environment. His work has led to advancements in medical treatments that could benefit many patients.

Collaborations

Some of Schow's notable coworkers include Semiramis Ayral-Kaloustian and Mila T Du. Their collaboration has likely contributed to the success of the projects they have worked on together.

Conclusion

Steven R. Schow's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…